Plasma Very Long Chain Fatty Acids

What is the purpose of the Plasma Very Long Chain Fatty Acids test?

The Plasma Very Long Chain Fatty Acids (VLCFA) test is a biochemical test primarily used to diagnose peroxisomal disorders, most notably X-linked adrenoleukodystrophy (X-ALD). These conditions result from impaired breakdown of VLCFAs due to enzyme deficiencies, leading to accumulation of these fatty acids in the body. The test measures levels of specific long-chain fatty acids in the blood to identify abnormal elevations that are indicative of metabolic disorders affecting lipid metabolism.


Who typically requires this test, and why is it ordered?

This test is usually ordered in individuals—especially children—who show signs of neurological regression, adrenal insufficiency, or other symptoms suggestive of metabolic or peroxisomal disorders. It may also be used in newborn screening programs or to assess family members of individuals already diagnosed with conditions like ALD. Timely diagnosis can help initiate appropriate monitoring and supportive treatment strategies.


How is the test conducted and what kind of sample is required?

The test requires a blood sample drawn from a vein, usually in the arm. After collection, the blood is processed to separate the plasma, where fatty acids are measured using techniques such as gas chromatography-mass spectrometry (GC-MS). The accuracy of this test depends on proper sample handling, so timely processing and transport to the lab is essential.


What do abnormal VLCFA levels indicate?

Elevated levels of VLCFAs in plasma suggest a defect in peroxisomal beta-oxidation, which is characteristic of disorders such as adrenoleukodystrophy or Zellweger spectrum disorders. The specific pattern of fatty acids—like C24:0 and C26:0 ratios—can provide clues about the underlying disorder. While this test is diagnostic, further genetic testing may be needed to confirm the exact type of metabolic disorder.


Are there any follow-up steps after receiving abnormal results?

If the results are abnormal, genetic counseling and molecular testing are typically recommended to confirm the diagnosis and identify specific gene mutations. Based on the diagnosis, further evaluations such as adrenal function tests, neurological assessments, or MRI scans may be performed. In families with a known history of peroxisomal disorders, siblings or relatives may also be tested for carrier status or early detection.